PCM
CLB icon

Prelude Capital Management’s Core Laboratories CLB Stock Holding History

Prelude Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,422
Closed -$67K – 1372
2020
Q3 		$67K Buy
4,422
+1,790
+68% +$37.5K ﹤0.01% 1039
2020
Q2 		$53K Sell
2,632
-3,521
-57% -$63.1K ﹤0.01% 1144
2020
Q1 		$64K Buy
+6,153
New +$172K ﹤0.01% 698
2018
Q4 		– Sell
-6,308
Closed -$731K – 1815
2018
Q3 		$731K Sell
6,308
-223
-3% -$25.2K 0.04% 435
2018
Q2 		$824K Sell
6,531
-7,114
-52% -$866K 0.05% 384
2018
Q1 		$1.48M Buy
13,645
+3,568
+35% +$395K 0.11% 187
2017
Q4 		$1.1M Buy
+10,077
New +$1.01M 0.09% 240
2015
Q3 		– Sell
-50
Closed -$6K – 1514
2015
Q2 		$6K Sell
50
-350
-88% -$42.4K ﹤0.01% 1606
2015
Q1 		$42K Buy
+400
New +$42.6K 0.01% 1393
2014
Q3 		– Sell
-120
Closed -$20K – 1886
2014
Q2 		$20K Buy
+120
New +$21.3K ﹤0.01% 1715
2014
Q1 		– Sell
-50
Closed -$10K – 1894
2013
Q4 		$10K Sell
50
-10
-17% -$1.86K ﹤0.01% 1499
2013
Q3 		$10K Buy
+60
New +$9.31K ﹤0.01% 1287

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Prelude Capital Management's CLB Position: Q4 2020 in Review

Prelude Capital Management sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 4,422 shares — an estimated $67K sold.

Prelude Capital Management first reported a position in CLB in Q3 2013 and held it in 12 quarters. The position peaked at $1.48M in Q1 2018. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

  • Prelude Capital Management reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
  • Prelude Capital Management sold 4,422 Core Laboratories shares in Q4 2020, an estimated $67K.
  • Prelude Capital Management first reported a position in Core Laboratories in Q3 2013 and held it in 12 quarters.
  • Prelude Capital Management's Core Laboratories position peaked at $1.48M in Q1 2018.
  • 181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.